Contributo scientifico, sviluppato generalmente su uno specifico argomento, che illustra risultati originali di una ricerca o presenta caratteristiche di review, cioè di discussione dello stato dell’arte o della letteratura entro un ambito scientifico definito. La rivista di pubblicazione deve presentare caratteristiche di scientificità. La tipologia non comprende editoriali, commenti brevi, repliche, abstract, errata, recensioni e prodotti similari, per i quali sono previste specifiche tipologie.
Subjects with blood group O are not at lower risk to acquire SARS-CoV-2 infection
2021 Gamal, N.; Villa, E.; Rolli, M.; Pecorari, M.; Mirabella, G.; Bertellini, E.; Ceccherelli, G.; Venturelli, D.
Phase 1b/2 trial of tepotinib in sorafenibpretreated advanced hepatocellular carcinoma with MET overexpression
2021 Decaens, T.; Barone, C.; Assenat, E.; Wermke, M.; Fasolo, A.; Merle, P.; Blanc, J. -F.; Grando, V.; Iacobellis, A.; Villa, E.; Trojan, J.; Straub, J.; Bruns, R.; Berghoff, K.; Scheele, J.; Raymond, E.; Faivre, S.
HCV cirrhotic patients treated with direct-acting antivirals: Detection of tubular dysfunction and resolution after viral clearance
2021 Biliotti, E.; Palazzo, D.; Tinti, F.; D'Alessandro, M. D.; Esvan, R.; Labriola, R.; Cappoli, A.; Umbro, I.; Volpicelli, L.; Bachetoni, A.; Villa, E.; Mitterhofer, A. P.; Rucci, P.; Taliani, G.
Clinical impact of sexual dimorphism in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
2021 Burra, P.; Bizzaro, D.; Gonta, A.; Shalaby, S.; Gambato, M.; Morelli, M. C.; Trapani, S.; Floreani, A.; Marra, F.; Brunetto, M. R.; Taliani, G.; Villa, E.
Retraction: The OMICs Window into Nonalcoholic Fatty Liver Disease (NAFLD) (Metabolites 2019, 9(2), 25)
2019 Carulli, L.; Zanca, G.; Schepis, F.; Villa, E.
Corrigendum: Evidence of a female-produced sex pheromone in the european pear psylla, cacopsylla pyri (Bulletin of Insectology 71, 1, 57-64, 2018)
2018 Ganassi, S.; Germinara, G. S.; Pati, S.; Civolani, S.; Cassanelli, S.; Sabatini, M. A.; De Cristofaro, A.
Anti-miR-518d-5p overcomes liver tumor cell death resistance through mitochondrial activity
2021 Fernandez-Tussy, P.; Rodriguez-Agudo, R.; Fernandez-Ramos, D.; Barbier-Torres, L.; Zubiete-Franco, I.; Davalillo, S. L.; Herraez, E.; Goikoetxea-Usandizaga, N.; Lachiondo-Ortega, S.; Simon, J.; Lopitz-Otsoa, F.; Juan, V. G. -D.; Mccain, M. V.; Perugorria, M. J.; Mabe, J.; Navasa, N.; Rodrigues, C. M. P.; Fabregat, I.; Boix, L.; Sapena, V.; Anguita, J.; Lu, S. C.; Mato, J. M.; Banales, J. M.; Villa, E.; Reeves, H. L.; Bruix, J.; Reig, M.; Marin, J. J. G.; Delgado, T. C.; Martinez-Chantar, M. L.
Correction: Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpression (British Journal of Cancer, (2021), 125, 2, (190-199), 10.1038/s41416-021-01334-9)
2021 Decaens, T.; Barone, C.; Assenat, E.; Wermke, M.; Fasolo, A.; Merle, P.; Blanc, J. -F.; Grando, V.; Iacobellis, A.; Villa, E.; Trojan, J.; Straub, J.; Bruns, R.; Berghoff, K.; Scheele, J.; Raymond, E.; Faivre, S.
Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19
2021 Villa, E.; Critelli, R.; Lasagni, S.; Melegari, A.; Curatolo, A.; Celsa, C.; Romagnoli, D.; Melegari, G.; Pivetti, A.; Di Marco, L.; Casari, F.; Arioli, D.; Turrini, F.; Zuccaro, V.; Cassaniti, I.; Riefolo, M.; De Santis, E.; Bernabucci, V.; Bianchini, M.; Lei, B.; De Maria, N.; Carulli, L.; Schepis, F.; Gozzi, C.; Malaguti, S.; Del Buono, M.; Brugioni, L.; Torricelli, P.; Trenti, T.; Pinelli, G.; Bertellini, E.; Bruno, R.; Camma, C.; D'Errico, A.
Transposon-mediated insertional mutagenesis unmasks recessive insecticide resistance in the aphid Myzus persicae
2021 Panini, M.; Chiesa, O.; Troczka, B. J.; Mallott, M.; Manicardi, G. C.; Cassanelli, S.; Cominelli, F.; Hayward, A.; Mazzoni, E.; Bass, C.
That’s the sex, baby, and there’s nothing you can do about it!
2021 De Maria, N.; Villa, E.
Evaluation of insecticide efficacy and insecticide adaptive response in italian populations of drosophila suzukii
2021 Civolani, S.; Vaccari, G.; Caruso, S.; Finetti, L.; Bernacchia, G.; Chicca, M.; Cassanelli, S.
Determination of volatiles in spirits using combined stationary phases in capillary GC
1995 Antonelli, A.; Galli, M.
The GISL HD2000 trial comparing ABVD with BEACOPP and with CEC as initial treatment of patients with advanced Hodgkin lymphoma
2009 Luminari, S.; Federico, M.
Nonpeghylated liposomal doxorubicin combination regimen (R-COMP) for the treatment of lymphoma patients with advanced age or cardiac comorbidity
2020 Rigacci, L.; Annibali, O.; Kovalchuk, S.; Bonifacio, E.; Pregnolato, F.; Angrilli, F.; Vitolo, U.; Pozzi, S.; Broggi, S.; Luminari, S.; Merli, F.; Spina, M.; Bolis, S.; Margiotta-Casaluci, G.; Scalzulli, R.; Cox, C.; Mamusa, A. M.; Santoro, A.; Zinzani, P. L.; Ferrari, S.; Gini, G.; Vigliotti, M. L.; Mule, A.; Flenghi, L.
Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: A study on behalf of the Fondazione Italiana Linfomi
2014 Merli, M.; Visco, C.; Spina, M.; Luminari, S.; Ferretti, V. V.; Gotti, M.; Rattotti, S.; Fiaccadori, V.; Rusconi, C.; Targhetta, C.; Stelitano, C.; Levis, A.; Ambrosetti, A.; Rossi, D.; Rigacci, L.; D'Arco, A. M.; Musto, P.; Chiappella, A.; Baldini, L.; Bonfichi, M.; Arcaini, L.
Five-year results of the BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma
2020 Santoro, A.; Mazza, R.; Pulsoni, A.; Re, A.; Bonfichi, M.; Zilioli, V. R.; Zanni, M.; Merli, F.; Anastasia, A.; Luminari, S.; Annechini, G.; Gotti, M.; Peli, A.; Liberati, A. M.; Di Renzo, N.; Castagna, L.; Giordano, L.; Ricci, F.; Carlo-Stella, C.
Early palliative care versus standard care in haematologic cancer patients at their last active treatment: Study protocol of a feasibility trial
2020 Tanzi, S.; Luminari, S.; Cavuto, S.; Turola, E.; Ghirotto, L.; Costantini, M.
Centroblastic (CB) and immunoblastic (IB) subtypes of diffuse large B cell lymphomas (DLBCL) have such a different clinical outcome that should be considered as separate entities in the WHO classification of lymphomas. A GISL study
2005 Federico, Massimo; Artusi, T; Luminari, Stefano; Brugiatelli, M; Ricciotti, M; Marcheselli, L; Molica, S; Lombardo, M; Angrilli, F; Polimeno, G; Gobbi, P.
The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions
2021 Bennett, C. L.; Nagai, S.; Bennett, A. C.; Hoque, S.; Nabhan, C.; Schoen, M. W.; Hrushesky, W. J.; Luminari, S.; Ray, P.; Yarnold, P. R.; Witherspoon, B.; Riente, J.; Bobolts, L.; Brusk, J.; Tombleson, R.; Knopf, K.; Fishman, M.; Llm, Y. T. Y.; Carson, K. R.; Djulbegovic, B.; Restaino, J.; Armitage, J. O.; Sartor, O. A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Subjects with blood group O are not at lower risk to acquire SARS-CoV-2 infection | 1-gen-2021 | Gamal, N.; Villa, E.; Rolli, M.; Pecorari, M.; Mirabella, G.; Bertellini, E.; Ceccherelli, G.; Venturelli, D. | |
| Phase 1b/2 trial of tepotinib in sorafenibpretreated advanced hepatocellular carcinoma with MET overexpression | 1-gen-2021 | Decaens, T.; Barone, C.; Assenat, E.; Wermke, M.; Fasolo, A.; Merle, P.; Blanc, J. -F.; Grando, V.; Iacobellis, A.; Villa, E.; Trojan, J.; Straub, J.; Bruns, R.; Berghoff, K.; Scheele, J.; Raymond, E.; Faivre, S. | |
| HCV cirrhotic patients treated with direct-acting antivirals: Detection of tubular dysfunction and resolution after viral clearance | 1-gen-2021 | Biliotti, E.; Palazzo, D.; Tinti, F.; D'Alessandro, M. D.; Esvan, R.; Labriola, R.; Cappoli, A.; Umbro, I.; Volpicelli, L.; Bachetoni, A.; Villa, E.; Mitterhofer, A. P.; Rucci, P.; Taliani, G. | |
| Clinical impact of sexual dimorphism in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) | 1-gen-2021 | Burra, P.; Bizzaro, D.; Gonta, A.; Shalaby, S.; Gambato, M.; Morelli, M. C.; Trapani, S.; Floreani, A.; Marra, F.; Brunetto, M. R.; Taliani, G.; Villa, E. | |
| Retraction: The OMICs Window into Nonalcoholic Fatty Liver Disease (NAFLD) (Metabolites 2019, 9(2), 25) | 1-gen-2019 | Carulli, L.; Zanca, G.; Schepis, F.; Villa, E. | |
| Corrigendum: Evidence of a female-produced sex pheromone in the european pear psylla, cacopsylla pyri (Bulletin of Insectology 71, 1, 57-64, 2018) | 1-gen-2018 | Ganassi, S.; Germinara, G. S.; Pati, S.; Civolani, S.; Cassanelli, S.; Sabatini, M. A.; De Cristofaro, A. | |
| Anti-miR-518d-5p overcomes liver tumor cell death resistance through mitochondrial activity | 1-gen-2021 | Fernandez-Tussy, P.; Rodriguez-Agudo, R.; Fernandez-Ramos, D.; Barbier-Torres, L.; Zubiete-Franco, I.; Davalillo, S. L.; Herraez, E.; Goikoetxea-Usandizaga, N.; Lachiondo-Ortega, S.; Simon, J.; Lopitz-Otsoa, F.; Juan, V. G. -D.; Mccain, M. V.; Perugorria, M. J.; Mabe, J.; Navasa, N.; Rodrigues, C. M. P.; Fabregat, I.; Boix, L.; Sapena, V.; Anguita, J.; Lu, S. C.; Mato, J. M.; Banales, J. M.; Villa, E.; Reeves, H. L.; Bruix, J.; Reig, M.; Marin, J. J. G.; Delgado, T. C.; Martinez-Chantar, M. L. | |
| Correction: Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpression (British Journal of Cancer, (2021), 125, 2, (190-199), 10.1038/s41416-021-01334-9) | 1-gen-2021 | Decaens, T.; Barone, C.; Assenat, E.; Wermke, M.; Fasolo, A.; Merle, P.; Blanc, J. -F.; Grando, V.; Iacobellis, A.; Villa, E.; Trojan, J.; Straub, J.; Bruns, R.; Berghoff, K.; Scheele, J.; Raymond, E.; Faivre, S. | |
| Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19 | 1-gen-2021 | Villa, E.; Critelli, R.; Lasagni, S.; Melegari, A.; Curatolo, A.; Celsa, C.; Romagnoli, D.; Melegari, G.; Pivetti, A.; Di Marco, L.; Casari, F.; Arioli, D.; Turrini, F.; Zuccaro, V.; Cassaniti, I.; Riefolo, M.; De Santis, E.; Bernabucci, V.; Bianchini, M.; Lei, B.; De Maria, N.; Carulli, L.; Schepis, F.; Gozzi, C.; Malaguti, S.; Del Buono, M.; Brugioni, L.; Torricelli, P.; Trenti, T.; Pinelli, G.; Bertellini, E.; Bruno, R.; Camma, C.; D'Errico, A. | |
| Transposon-mediated insertional mutagenesis unmasks recessive insecticide resistance in the aphid Myzus persicae | 1-gen-2021 | Panini, M.; Chiesa, O.; Troczka, B. J.; Mallott, M.; Manicardi, G. C.; Cassanelli, S.; Cominelli, F.; Hayward, A.; Mazzoni, E.; Bass, C. | |
| That’s the sex, baby, and there’s nothing you can do about it! | 1-gen-2021 | De Maria, N.; Villa, E. | |
| Evaluation of insecticide efficacy and insecticide adaptive response in italian populations of drosophila suzukii | 1-gen-2021 | Civolani, S.; Vaccari, G.; Caruso, S.; Finetti, L.; Bernacchia, G.; Chicca, M.; Cassanelli, S. | |
| Determination of volatiles in spirits using combined stationary phases in capillary GC | 1-gen-1995 | Antonelli, A.; Galli, M. | |
| The GISL HD2000 trial comparing ABVD with BEACOPP and with CEC as initial treatment of patients with advanced Hodgkin lymphoma | 1-gen-2009 | Luminari, S.; Federico, M. | |
| Nonpeghylated liposomal doxorubicin combination regimen (R-COMP) for the treatment of lymphoma patients with advanced age or cardiac comorbidity | 1-gen-2020 | Rigacci, L.; Annibali, O.; Kovalchuk, S.; Bonifacio, E.; Pregnolato, F.; Angrilli, F.; Vitolo, U.; Pozzi, S.; Broggi, S.; Luminari, S.; Merli, F.; Spina, M.; Bolis, S.; Margiotta-Casaluci, G.; Scalzulli, R.; Cox, C.; Mamusa, A. M.; Santoro, A.; Zinzani, P. L.; Ferrari, S.; Gini, G.; Vigliotti, M. L.; Mule, A.; Flenghi, L. | |
| Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: A study on behalf of the Fondazione Italiana Linfomi | 1-gen-2014 | Merli, M.; Visco, C.; Spina, M.; Luminari, S.; Ferretti, V. V.; Gotti, M.; Rattotti, S.; Fiaccadori, V.; Rusconi, C.; Targhetta, C.; Stelitano, C.; Levis, A.; Ambrosetti, A.; Rossi, D.; Rigacci, L.; D'Arco, A. M.; Musto, P.; Chiappella, A.; Baldini, L.; Bonfichi, M.; Arcaini, L. | |
| Five-year results of the BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma | 1-gen-2020 | Santoro, A.; Mazza, R.; Pulsoni, A.; Re, A.; Bonfichi, M.; Zilioli, V. R.; Zanni, M.; Merli, F.; Anastasia, A.; Luminari, S.; Annechini, G.; Gotti, M.; Peli, A.; Liberati, A. M.; Di Renzo, N.; Castagna, L.; Giordano, L.; Ricci, F.; Carlo-Stella, C. | |
| Early palliative care versus standard care in haematologic cancer patients at their last active treatment: Study protocol of a feasibility trial | 1-gen-2020 | Tanzi, S.; Luminari, S.; Cavuto, S.; Turola, E.; Ghirotto, L.; Costantini, M. | |
| Centroblastic (CB) and immunoblastic (IB) subtypes of diffuse large B cell lymphomas (DLBCL) have such a different clinical outcome that should be considered as separate entities in the WHO classification of lymphomas. A GISL study | 1-gen-2005 | Federico, Massimo; Artusi, T; Luminari, Stefano; Brugiatelli, M; Ricciotti, M; Marcheselli, L; Molica, S; Lombardo, M; Angrilli, F; Polimeno, G; Gobbi, P. | |
| The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions | 1-gen-2021 | Bennett, C. L.; Nagai, S.; Bennett, A. C.; Hoque, S.; Nabhan, C.; Schoen, M. W.; Hrushesky, W. J.; Luminari, S.; Ray, P.; Yarnold, P. R.; Witherspoon, B.; Riente, J.; Bobolts, L.; Brusk, J.; Tombleson, R.; Knopf, K.; Fishman, M.; Llm, Y. T. Y.; Carson, K. R.; Djulbegovic, B.; Restaino, J.; Armitage, J. O.; Sartor, O. A. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- Contributo su RIVISTA69883
- Atti di CONVEGNO1
- Contributo su VOLUME1
Data di pubblicazione
- 2020 - 202720219
- 2010 - 201923518
- 2000 - 200914314
- 1990 - 19998031
- 1980 - 19893149
- 1970 - 1979640
- 1966 - 196911
Editore
- Elsevier BV:PO Box 211, 1000 AE A...334
- American Institute of Physics:2 H...226
- Elsevier Science Limited:Oxford F...189
- Giuffre Editore Spa:via Busto Ars...101
- Societa Editrice il Mulino Spa:St...73
- Springer Verlag Germany:Tiergarte...71
- IEEE / Institute of Electrical an...70
- Academic Press Incorporated:6277 ...67
- American Chemical Society:1155 Si...63
- Edizioni Minerva Medica:Corso Bra...59
Rivista
- JOURNAL OF HIGH ENERGY PHYSICS404
- EFSA JOURNAL380
- PLOS ONE315
- PHYSICAL REVIEW LETTERS309
- PHYSICAL REVIEW. B, CONDENSED MAT...294
- SCIENTIFIC REPORTS290
Serie
- EUROPEAN DISTANCE AND E-LEARNING ...1
Keyword
- Humans4564
- Female2680
- Male2251
- Middle Aged1673
- Adult1526
- Aged1328
- Italy768
- Treatment Outcome649
- COVID-19587
- 80 and over506
Lingua
- eng58341
- ita10788
- fre334
- spa300
- ger189
- por61
- rus24
- und23
- chi15
- pol7
Accesso al fulltext
- no fulltext29934
- open19790
- reserved18704
- partially open1441
- embargoed15
- mixed1
